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Dear Editor 
Non-tuberculons Mycobacteria 
The informative paper by Hosker et al. (1) on the 
prevalence of ‘pulmonary infection due to non- 
tuberculous mycobacteria’ in Hong Kong provides 
an occasion for drawing attention to the verbal 
confusions arising from the illogical decision to adopt 
the specific name ‘tuberculosis’ for the species of 
mycobacterium most commonly associated with 
tuberculosis in the human subject. In colloquial dis- 
course, this organism has been called the human 
tubercle bacillus with clarity and propriety, and it 
is regrettable that this term was not translated 
into Latin as Mycobacterium hominis in the formal 
terminology of the mycobacteria. 
We should not confuse a disease with its own 
cause. ‘Tuberculosis’ currently refers to a disease 
characterized by granulomatous changes caused by a 
mycobacterium. This diagnosis places the patient in a 
category with defining characteristics in two fields, 
morbid anatomy and aetiology. A complete diag- 
nostic statement would include identification of the 
causal mycobacterium. When a diagnosis of tubercu- 
losis, unspecified, is made in man it is implied that the 
causal organism is thought, or has been shown, to be 
the human tubercle bacillus. In the days when disease 
caused by Mycobacterium bovis was important in 
man, it was referred to as bovine tuberculosis, imply- 
ing with perfect clarity a disease caused by the species 
of mycobacterium most commonly causing disease in 
cattle. The adoption of the name hominis for the 
species most prevalent in the human race would have 
been logical and convenient, and would not have 
implied that only the disease caused by this species is 
properly called tuberculosis in man, leaving granulo- 
matous diseases caused in man by other species of 
mycobacteria in limbo (2). 
With this terminology, the phrase ‘Pulmonary 
infection by mycobacteria other than M. hominis’ 
would have indicated clearly the subject of the Hong 
Kong paper without suggesting that some other 
name should be found for morbid-anatomical 
tuberculosis caused by other species of mycobacteria. 
J. G. SCADDING 
Emeritus Professor of Medicine 
6 February 1995 
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Reply to Prof Scadding 
We thank Professor Scadding for his interest in 
our work and share his concerns regarding the 
confusion regarding terminology for Mycobacterial 
disease. 
Our use of the term non-tuberculous mycobacteria 
was chosen as the one most widely used at the 
present time to describe Mycobacteria, other than 
Mycobacterium tuberculosis. 
We look forward to the time when a definitive 
terminology is agreed by all scientists and clinicians. 
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